Can 75mg of Trazodone (triazolopyridine antidepressant) cause tremors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone and Tremors: Clinical Evidence and Management

Yes, 75mg of trazodone can cause tremors as this is a documented adverse effect listed in the FDA drug label. 1

Evidence for Trazodone-Induced Tremors

  • The FDA drug label for trazodone specifically lists tremors as an adverse reaction, occurring in approximately 3-5% of patients taking the medication 1
  • Tremors are listed among the neurological adverse effects that can occur even at therapeutic doses, not just in overdose situations 1
  • According to Praxis Medical Insights, trazodone can cause tremors, with cardiac patients potentially at higher risk for both movement disorders and cardiac arrhythmias 2
  • A recent case report (2022) documented trazodone-induced parkinsonism in a 78-year-old male, which included coarse tremors of the upper extremities that resolved within a week after discontinuation of the medication 3

Mechanism of Trazodone-Induced Tremors

  • Trazodone is a serotonin receptor antagonist and reuptake inhibitor (SARI) that affects multiple neurotransmitter systems 4
  • The exact mechanism for tremor induction is not fully understood, but likely involves the interaction between serotonergic and dopaminergic systems 3
  • At low doses, trazodone acts as a serotonin antagonist, while at higher doses it functions as a serotonin agonist, which may contribute to its neurological side effects 5

Risk Factors for Developing Tremors on Trazodone

  • Elderly patients may be at higher risk for developing movement disorders including tremors 3
  • Patients taking medications that may interact with trazodone's metabolism (such as amiodarone) could experience higher blood levels and increased risk of adverse effects including tremors 3
  • Polypharmacy can amplify the adverse effects of trazodone that might not be commonly observed in routine practice 3

Management of Trazodone-Induced Tremors

  • If tremors develop while taking trazodone, discontinuation of the medication should be considered, as symptoms may resolve within days to weeks after stopping the drug 3
  • For patients requiring antidepressant therapy who develop tremors on trazodone, the American Academy of Family Physicians recommends considering switching to agents with lower reported incidence of movement disorders 2
  • Dose reduction might be considered before complete discontinuation, especially if the patient is experiencing beneficial effects from trazodone 4
  • Monitoring for other extrapyramidal symptoms is important, as tremors may be part of a broader movement disorder 3

Other Important Considerations

  • Trazodone can cause additional neurological adverse effects including incoordination (5%), muscle twitches, numbness, and paresthesia 1
  • The medication can also cause cardiac arrhythmias, including QT prolongation and torsade de pointes, particularly in patients with pre-existing cardiac disease 1
  • Orthostatic hypotension and syncope are other potential adverse effects that may accompany or be confused with tremors 1
  • When prescribing trazodone, start with lower doses in elderly patients and those with hepatic impairment to minimize adverse effects 4

In conclusion, while trazodone is generally well-tolerated compared to some other antidepressants, tremors are a recognized adverse effect that can occur at therapeutic doses including 75mg. Patients experiencing tremors should be evaluated for potential discontinuation or switching to an alternative medication.

References

Guideline

Trazodone-Induced Tremors: Clinical Evidence and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Trazodone-induced parkinsonism: A case report.

International journal of clinical pharmacology and therapeutics, 2022

Research

Antidepressant properties of trazodone.

Clinical pharmacy, 1982

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.